

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of gastrointestinal epithelium (GO:0030277) | 7.64184756 |
| 2 | oligosaccharide biosynthetic process (GO:0009312) | 7.03518829 |
| 3 | behavioral response to nicotine (GO:0035095) | 6.44389873 |
| 4 | O-glycan processing (GO:0016266) | 6.05968767 |
| 5 | epithelial structure maintenance (GO:0010669) | 5.78180693 |
| 6 | regulation of proton transport (GO:0010155) | 5.47374017 |
| 7 | tryptophan catabolic process (GO:0006569) | 4.55171295 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.55171295 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.55171295 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.54843192 |
| 11 | acyl-CoA biosynthetic process (GO:0071616) | 4.51321213 |
| 12 | thioester biosynthetic process (GO:0035384) | 4.51321213 |
| 13 | digestion (GO:0007586) | 4.45675590 |
| 14 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.35231773 |
| 15 | regulation of sequestering of triglyceride (GO:0010889) | 4.26618240 |
| 16 | carnitine shuttle (GO:0006853) | 4.22235523 |
| 17 | extracellular fibril organization (GO:0043206) | 4.19354916 |
| 18 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.18761159 |
| 19 | indolalkylamine metabolic process (GO:0006586) | 4.16925533 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09078286 |
| 21 | protein O-linked glycosylation (GO:0006493) | 4.04314004 |
| 22 | fatty acid transmembrane transport (GO:1902001) | 4.04222073 |
| 23 | fucose catabolic process (GO:0019317) | 3.99693885 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.99693885 |
| 25 | L-fucose catabolic process (GO:0042355) | 3.99693885 |
| 26 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.94837811 |
| 27 | positive regulation of macrophage cytokine production (GO:0060907) | 3.91131341 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.86460072 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.86460072 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.86460072 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.86460072 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.86460072 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.86460072 |
| 34 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.86382608 |
| 35 | regulation of phospholipase A2 activity (GO:0032429) | 3.82995126 |
| 36 | neuronal action potential (GO:0019228) | 3.82355865 |
| 37 | positive regulation of p38MAPK cascade (GO:1900745) | 3.73363470 |
| 38 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.73239458 |
| 39 | tryptophan metabolic process (GO:0006568) | 3.71538945 |
| 40 | fibril organization (GO:0097435) | 3.69478963 |
| 41 | icosanoid secretion (GO:0032309) | 3.68680145 |
| 42 | arachidonic acid secretion (GO:0050482) | 3.68680145 |
| 43 | primary amino compound metabolic process (GO:1901160) | 3.68652338 |
| 44 | long-chain fatty acid transport (GO:0015909) | 3.66694510 |
| 45 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.66462760 |
| 46 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.65203173 |
| 47 | mammary gland epithelial cell differentiation (GO:0060644) | 3.65140772 |
| 48 | serotonin metabolic process (GO:0042428) | 3.62348937 |
| 49 | indole-containing compound metabolic process (GO:0042430) | 3.59061802 |
| 50 | * digestive system process (GO:0022600) | 3.57871523 |
| 51 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.56608019 |
| 52 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.49556719 |
| 53 | detection of light stimulus involved in visual perception (GO:0050908) | 3.49556719 |
| 54 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.44964220 |
| 55 | linoleic acid metabolic process (GO:0043651) | 3.44355084 |
| 56 | regulation of action potential (GO:0098900) | 3.42002932 |
| 57 | biotin metabolic process (GO:0006768) | 3.39551677 |
| 58 | fatty acid derivative transport (GO:1901571) | 3.35541188 |
| 59 | icosanoid transport (GO:0071715) | 3.35541188 |
| 60 | positive regulation of action potential (GO:0045760) | 3.33514417 |
| 61 | glutathione derivative biosynthetic process (GO:1901687) | 3.32887980 |
| 62 | glutathione derivative metabolic process (GO:1901685) | 3.32887980 |
| 63 | response to pheromone (GO:0019236) | 3.32644712 |
| 64 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.31786035 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.31021297 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.30577005 |
| 67 | behavioral response to ethanol (GO:0048149) | 3.28186903 |
| 68 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.27465874 |
| 69 | fatty acid transport (GO:0015908) | 3.23623083 |
| 70 | macrophage activation involved in immune response (GO:0002281) | 3.22109067 |
| 71 | ectoderm development (GO:0007398) | 3.21749770 |
| 72 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18489984 |
| 73 | response to iron ion (GO:0010039) | 3.18272769 |
| 74 | reflex (GO:0060004) | 3.17779868 |
| 75 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.17668311 |
| 76 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.16512848 |
| 77 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.16512848 |
| 78 | amine catabolic process (GO:0009310) | 3.16280258 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 3.16280258 |
| 80 | DNA deamination (GO:0045006) | 3.15939582 |
| 81 | thyroid hormone metabolic process (GO:0042403) | 3.15558418 |
| 82 | pattern specification involved in kidney development (GO:0061004) | 3.14962081 |
| 83 | triglyceride biosynthetic process (GO:0019432) | 3.14726793 |
| 84 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.13212985 |
| 85 | apoptotic cell clearance (GO:0043277) | 3.12984886 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12819174 |
| 87 | epithelial cilium movement (GO:0003351) | 3.12543004 |
| 88 | pH reduction (GO:0045851) | 3.10661350 |
| 89 | cornea development in camera-type eye (GO:0061303) | 3.09791114 |
| 90 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.08155374 |
| 91 | negative regulation of mast cell activation (GO:0033004) | 3.07970734 |
| 92 | carnitine transmembrane transport (GO:1902603) | 3.06754599 |
| 93 | regulation of macrophage cytokine production (GO:0010935) | 3.04037877 |
| 94 | neutral lipid biosynthetic process (GO:0046460) | 3.03787765 |
| 95 | acylglycerol biosynthetic process (GO:0046463) | 3.03787765 |
| 96 | negative regulation of telomere maintenance (GO:0032205) | 3.03543866 |
| 97 | neutrophil mediated immunity (GO:0002446) | 3.01805261 |
| 98 | neural tube formation (GO:0001841) | 3.01593586 |
| 99 | regulation of early endosome to late endosome transport (GO:2000641) | 3.00715954 |
| 100 | ketone body metabolic process (GO:1902224) | 3.00029327 |
| 101 | rRNA catabolic process (GO:0016075) | 2.98572750 |
| 102 | regulation of p38MAPK cascade (GO:1900744) | 2.97309007 |
| 103 | intracellular lipid transport (GO:0032365) | 2.97010636 |
| 104 | cellular response to ATP (GO:0071318) | 2.96401494 |
| 105 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.96391256 |
| 106 | lactation (GO:0007595) | 2.94217915 |
| 107 | protein localization to endosome (GO:0036010) | 2.93515177 |
| 108 | N-acetylneuraminate metabolic process (GO:0006054) | 2.92564630 |
| 109 | platelet dense granule organization (GO:0060155) | 2.92112039 |
| 110 | synaptic transmission, cholinergic (GO:0007271) | 2.90331289 |
| 111 | leukotriene metabolic process (GO:0006691) | 2.89974916 |
| 112 | piRNA metabolic process (GO:0034587) | 2.88481002 |
| 113 | microglial cell activation (GO:0001774) | 2.87649744 |
| 114 | nephron epithelium morphogenesis (GO:0072088) | 2.86788055 |
| 115 | nephron tubule morphogenesis (GO:0072078) | 2.86788055 |
| 116 | startle response (GO:0001964) | 2.86407979 |
| 117 | amino-acid betaine transport (GO:0015838) | 2.86057713 |
| 118 | carnitine transport (GO:0015879) | 2.86057713 |
| 119 | secretion by tissue (GO:0032941) | 2.85662215 |
| 120 | nonmotile primary cilium assembly (GO:0035058) | 2.85577535 |
| 121 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.84916822 |
| 122 | response to host (GO:0075136) | 2.84916822 |
| 123 | response to host defenses (GO:0052200) | 2.84916822 |
| 124 | leukotriene biosynthetic process (GO:0019370) | 2.83935802 |
| 125 | membrane depolarization during action potential (GO:0086010) | 2.83475212 |
| 126 | sodium ion export (GO:0071436) | 2.82226130 |
| 127 | response to host immune response (GO:0052572) | 2.78723919 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78723919 |
| 129 | axoneme assembly (GO:0035082) | 2.78579457 |
| 130 | thyroid hormone generation (GO:0006590) | 2.78575787 |
| 131 | protein polyglutamylation (GO:0018095) | 2.78142327 |
| 132 | parturition (GO:0007567) | 2.77802710 |
| 133 | sulfation (GO:0051923) | 2.77145322 |
| 134 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.76844172 |
| 135 | action potential (GO:0001508) | 2.76542222 |
| 136 | cilium movement (GO:0003341) | 2.76312019 |
| 137 | acetyl-CoA metabolic process (GO:0006084) | 2.75277969 |
| 138 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.74521907 |
| 139 | nucleobase catabolic process (GO:0046113) | 2.73039272 |
| 140 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.71998761 |
| 141 | regulation of hippo signaling (GO:0035330) | 2.67985833 |
| 142 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.67574644 |
| 143 | vitamin transport (GO:0051180) | 2.66899701 |
| 144 | hindbrain development (GO:0030902) | 2.66737687 |
| 145 | protein localization to cilium (GO:0061512) | 2.66285383 |
| 146 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.65324415 |
| 147 | auditory receptor cell stereocilium organization (GO:0060088) | 2.64741749 |
| 148 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.63074113 |
| 149 | regulation of gene silencing by miRNA (GO:0060964) | 2.63074113 |
| 150 | regulation of gene silencing by RNA (GO:0060966) | 2.63074113 |
| 151 | glycerophospholipid catabolic process (GO:0046475) | 2.62567390 |
| 152 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.61769598 |
| 153 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.61676510 |
| 154 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.60966216 |
| 155 | benzene-containing compound metabolic process (GO:0042537) | 2.60599603 |
| 156 | intestinal absorption (GO:0050892) | 2.59866083 |
| 157 | aromatic amino acid family catabolic process (GO:0009074) | 2.58669488 |
| 158 | cilium morphogenesis (GO:0060271) | 2.57739540 |
| 159 | pentose-phosphate shunt (GO:0006098) | 2.57344684 |
| 160 | postsynaptic membrane organization (GO:0001941) | 2.56510210 |
| 161 | NAD biosynthetic process (GO:0009435) | 2.56000950 |
| 162 | photoreceptor cell maintenance (GO:0045494) | 2.55888380 |
| 163 | cilium organization (GO:0044782) | 2.55150300 |
| 164 | positive regulation of lipid storage (GO:0010884) | 2.52762535 |
| 165 | sialylation (GO:0097503) | 2.52396681 |
| 166 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.51933928 |
| 167 | axonemal dynein complex assembly (GO:0070286) | 2.51773769 |
| 168 | cellular response to arsenic-containing substance (GO:0071243) | 2.50930359 |
| 169 | cAMP catabolic process (GO:0006198) | 2.50702799 |
| 170 | nitric oxide biosynthetic process (GO:0006809) | 2.50250730 |
| 171 | * regulation of pH (GO:0006885) | 2.50229402 |
| 172 | inner ear receptor stereocilium organization (GO:0060122) | 2.49912925 |
| 173 | production of molecular mediator of immune response (GO:0002440) | 2.49384815 |
| 174 | kidney morphogenesis (GO:0060993) | 2.48697010 |
| 175 | retinal cone cell development (GO:0046549) | 2.48138679 |
| 176 | transmission of nerve impulse (GO:0019226) | 2.47707277 |
| 177 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.47233120 |
| 178 | cilium assembly (GO:0042384) | 2.47103116 |
| 179 | cell proliferation in forebrain (GO:0021846) | 2.46486469 |
| 180 | DNA methylation involved in gamete generation (GO:0043046) | 2.45082419 |
| 181 | neuronal action potential propagation (GO:0019227) | 2.44860051 |
| 182 | lipid storage (GO:0019915) | 2.44531900 |
| 183 | oligosaccharide metabolic process (GO:0009311) | 2.43951365 |
| 184 | photoreceptor cell development (GO:0042461) | 2.43136813 |
| 185 | exogenous drug catabolic process (GO:0042738) | 2.42784398 |
| 186 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.41762360 |
| 187 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.39178805 |
| 188 | rhodopsin mediated signaling pathway (GO:0016056) | 2.38972223 |
| 189 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.38353533 |
| 190 | drug catabolic process (GO:0042737) | 2.38141732 |
| 191 | regulation of cilium movement (GO:0003352) | 2.37466374 |
| 192 | neurotransmitter metabolic process (GO:0042133) | 2.37250634 |
| 193 | positive regulation of fatty acid transport (GO:2000193) | 2.36939264 |
| 194 | oxidative demethylation (GO:0070989) | 2.36493069 |
| 195 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.34448361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.29110249 |
| 2 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 3.93434403 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.58354075 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.56987072 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.23840878 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20741028 |
| 7 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.04116677 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.90349212 |
| 9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.85964790 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.80391667 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.74325537 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.62276601 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.61207720 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.30684596 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.24906965 |
| 16 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.18528901 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.14833282 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08545680 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07368237 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.06639166 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00317997 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.95558150 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95477410 |
| 24 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.90805442 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90428994 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.86012780 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.85500586 |
| 28 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83276404 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.82766666 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.81919453 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.79722680 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78582253 |
| 33 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73977536 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71361671 |
| 35 | RXR_22108803_ChIP-Seq_LS180_Human | 1.70843434 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67584018 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.67489092 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.66834642 |
| 39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.66024176 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62981071 |
| 41 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.61325319 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59298314 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57769010 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.57027451 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.55893711 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.55413896 |
| 47 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.55403601 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55267546 |
| 49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52326629 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52203107 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51875652 |
| 52 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50953483 |
| 53 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48930853 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48521651 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47824285 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.46390779 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.46270471 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45908545 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.45879590 |
| 60 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45090095 |
| 61 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.44362695 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44104576 |
| 63 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43372224 |
| 64 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.43035264 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40118770 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.39719730 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39719730 |
| 68 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39559073 |
| 69 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39411014 |
| 70 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.38975122 |
| 71 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37925643 |
| 72 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37111372 |
| 73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35673382 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35673382 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.33786598 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33336840 |
| 77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30304866 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30070142 |
| 79 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29929640 |
| 80 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.29046285 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28366648 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27515524 |
| 83 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26581412 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25249978 |
| 85 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25044947 |
| 86 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24872766 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.24737907 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.24737907 |
| 89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24717919 |
| 90 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.24500658 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24334168 |
| 92 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23750525 |
| 93 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23750525 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23673495 |
| 95 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23535982 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23323725 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22470818 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21307972 |
| 99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19657992 |
| 100 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19539052 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19249603 |
| 102 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18643543 |
| 103 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18520943 |
| 104 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.18312271 |
| 105 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.18292170 |
| 106 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17662145 |
| 107 | NCOR_22424771_ChIP-Seq_293T_Human | 1.17541965 |
| 108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17315147 |
| 109 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16944461 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15578881 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15475443 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14900821 |
| 113 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14280551 |
| 114 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14257023 |
| 115 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14245632 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13684578 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13230572 |
| 118 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12426754 |
| 119 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.12039346 |
| 120 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11994274 |
| 121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11897086 |
| 122 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11373423 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.11133943 |
| 124 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10756296 |
| 125 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10687463 |
| 126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10425350 |
| 127 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10056181 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09836415 |
| 129 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09420462 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09163542 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08982859 |
| 132 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08535406 |
| 133 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07445617 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07181799 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07181799 |
| 136 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07095378 |
| 137 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.06890435 |
| 138 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06290230 |
| 139 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05911769 |
| 140 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04804497 |
| 141 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04591658 |
| 142 | AR_20517297_ChIP-Seq_VCAP_Human | 1.04563583 |
| 143 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04273814 |
| 144 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03578773 |
| 145 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03407036 |
| 146 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02231306 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02203715 |
| 148 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01798825 |
| 149 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00758527 |
| 150 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00254876 |
| 151 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99579068 |
| 152 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99477580 |
| 153 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99159688 |
| 154 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.98765239 |
| 155 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98665772 |
| 156 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97643591 |
| 157 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96770429 |
| 158 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96085318 |
| 159 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95173371 |
| 160 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95173371 |
| 161 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95006930 |
| 162 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93746365 |
| 163 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93384238 |
| 164 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92903814 |
| 165 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92762452 |
| 166 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92265652 |
| 167 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92093410 |
| 168 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.91254716 |
| 169 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90482108 |
| 170 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90064707 |
| 171 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89542368 |
| 172 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88378975 |
| 173 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88290684 |
| 174 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88149894 |
| 175 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87778271 |
| 176 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87494045 |
| 177 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87449003 |
| 178 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87379627 |
| 179 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86053838 |
| 180 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85784219 |
| 181 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85769008 |
| 182 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85564794 |
| 183 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.85015298 |
| 184 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84863649 |
| 185 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84049216 |
| 186 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83242187 |
| 187 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83111159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001881_abnormal_mammary_gland | 6.14373943 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.84140847 |
| 3 | * MP0001664_abnormal_digestion | 3.76611714 |
| 4 | MP0005083_abnormal_biliary_tract | 2.92249412 |
| 5 | MP0003303_peritoneal_inflammation | 2.74788040 |
| 6 | MP0003195_calcinosis | 2.73891723 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.63217085 |
| 8 | * MP0001873_stomach_inflammation | 2.61531091 |
| 9 | * MP0000470_abnormal_stomach_morphology | 2.46541887 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.46356911 |
| 11 | MP0003646_muscle_fatigue | 2.44761970 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.40704609 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 2.36719913 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.27696841 |
| 15 | MP0003787_abnormal_imprinting | 2.25222572 |
| 16 | MP0002736_abnormal_nociception_after | 2.24211590 |
| 17 | MP0002102_abnormal_ear_morphology | 2.22577793 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.20408757 |
| 19 | MP0009046_muscle_twitch | 2.20186645 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.15697558 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.09874281 |
| 22 | MP0004130_abnormal_muscle_cell | 2.07823109 |
| 23 | MP0002653_abnormal_ependyma_morphology | 2.03326628 |
| 24 | MP0004885_abnormal_endolymph | 2.02973760 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.01275146 |
| 26 | MP0008004_abnormal_stomach_pH | 12.8242766 |
| 27 | MP0004142_abnormal_muscle_tone | 1.99913800 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.95414426 |
| 29 | MP0001485_abnormal_pinna_reflex | 1.91477198 |
| 30 | MP0008872_abnormal_physiological_respon | 1.90556809 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.88073258 |
| 32 | MP0002272_abnormal_nervous_system | 1.86518220 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.78345036 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 1.75275298 |
| 35 | MP0003878_abnormal_ear_physiology | 1.75275298 |
| 36 | MP0000627_abnormal_mammary_gland | 1.74622491 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.73632249 |
| 38 | MP0000427_abnormal_hair_cycle | 1.72672940 |
| 39 | MP0004043_abnormal_pH_regulation | 1.71712093 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.69928647 |
| 41 | MP0003075_altered_response_to | 1.69543193 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69247355 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.67013623 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.66974667 |
| 45 | MP0004133_heterotaxia | 1.66782975 |
| 46 | MP0002064_seizures | 1.64041798 |
| 47 | MP0005165_increased_susceptibility_to | 1.63293974 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.59395472 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.57189516 |
| 50 | MP0004742_abnormal_vestibular_system | 1.56815626 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.55871067 |
| 52 | MP0001486_abnormal_startle_reflex | 1.55538918 |
| 53 | MP0004510_myositis | 1.54612541 |
| 54 | * MP0001663_abnormal_digestive_system | 1.54240189 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.53530225 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.53428543 |
| 57 | MP0000631_abnormal_neuroendocrine_gland | 1.50239386 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.49931953 |
| 59 | MP0005253_abnormal_eye_physiology | 1.48651875 |
| 60 | MP0001970_abnormal_pain_threshold | 1.48545208 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.48374908 |
| 62 | MP0002938_white_spotting | 1.47871948 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.42033050 |
| 64 | MP0001919_abnormal_reproductive_system | 1.41810935 |
| 65 | MP0005389_reproductive_system_phenotype | 1.40919699 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.38126155 |
| 67 | MP0003880_abnormal_central_pattern | 1.37273374 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 1.34849809 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.34156884 |
| 70 | MP0004484_altered_response_of | 1.32734717 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.32191797 |
| 72 | MP0002928_abnormal_bile_duct | 1.30474873 |
| 73 | MP0002067_abnormal_sensory_capabilities | 1.29947504 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 1.27500340 |
| 75 | MP0002160_abnormal_reproductive_system | 1.27251963 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 1.25260607 |
| 77 | * MP0005381_digestive/alimentary_phenotyp | 1.24746419 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 1.22526762 |
| 79 | MP0005386_behavior/neurological_phenoty | 1.22086703 |
| 80 | MP0004924_abnormal_behavior | 1.22086703 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.18848155 |
| 82 | MP0001440_abnormal_grooming_behavior | 1.18267088 |
| 83 | MP0002234_abnormal_pharynx_morphology | 1.16426424 |
| 84 | MP0005310_abnormal_salivary_gland | 1.15971124 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.15318577 |
| 86 | MP0002163_abnormal_gland_morphology | 1.15300923 |
| 87 | MP0010329_abnormal_lipoprotein_level | 1.13972760 |
| 88 | MP0003718_maternal_effect | 1.13468598 |
| 89 | MP0000778_abnormal_nervous_system | 1.10347160 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 1.08031268 |
| 91 | MP0003137_abnormal_impulse_conducting | 1.07957567 |
| 92 | MP0002254_reproductive_system_inflammat | 1.06425825 |
| 93 | MP0005166_decreased_susceptibility_to | 1.05807796 |
| 94 | MP0003283_abnormal_digestive_organ | 1.04442058 |
| 95 | MP0005195_abnormal_posterior_eye | 1.03783634 |
| 96 | MP0002796_impaired_skin_barrier | 1.03272550 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 1.03027006 |
| 98 | MP0000026_abnormal_inner_ear | 1.02246344 |
| 99 | MP0000230_abnormal_systemic_arterial | 1.01082118 |
| 100 | MP0008961_abnormal_basal_metabolism | 1.00145610 |
| 101 | MP0001905_abnormal_dopamine_level | 0.97696406 |
| 102 | MP0009840_abnormal_foam_cell | 0.96060141 |
| 103 | MP0001963_abnormal_hearing_physiology | 0.93723483 |
| 104 | MP0003252_abnormal_bile_duct | 0.93385151 |
| 105 | MP0004947_skin_inflammation | 0.91873850 |
| 106 | MP0002752_abnormal_somatic_nervous | 0.91352038 |
| 107 | MP0005423_abnormal_somatic_nervous | 0.90260930 |
| 108 | MP0005410_abnormal_fertilization | 0.89861739 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.89541142 |
| 110 | MP0002419_abnormal_innate_immunity | 0.89332039 |
| 111 | MP0004215_abnormal_myocardial_fiber | 0.89254956 |
| 112 | MP0002909_abnormal_adrenal_gland | 0.88718148 |
| 113 | MP0004147_increased_porphyrin_level | 0.88497153 |
| 114 | MP0003121_genomic_imprinting | 0.88475139 |
| 115 | MP0003119_abnormal_digestive_system | 0.88466696 |
| 116 | MP0003122_maternal_imprinting | 0.87772817 |
| 117 | MP0002095_abnormal_skin_pigmentation | 0.87719441 |
| 118 | MP0004858_abnormal_nervous_system | 0.87123369 |
| 119 | MP0001984_abnormal_olfaction | 0.86244711 |
| 120 | MP0003329_amyloid_beta_deposits | 0.85569487 |
| 121 | MP0000490_abnormal_crypts_of | 0.85368656 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.83684811 |
| 123 | MP0002184_abnormal_innervation | 0.83168768 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.83147602 |
| 125 | MP0000383_abnormal_hair_follicle | 0.83095152 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.83092966 |
| 127 | MP0003011_delayed_dark_adaptation | 0.82003061 |
| 128 | MP0005334_abnormal_fat_pad | 0.80943142 |
| 129 | MP0002229_neurodegeneration | 0.80581089 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.79488377 |
| 131 | MP0005670_abnormal_white_adipose | 0.78908864 |
| 132 | MP0002971_abnormal_brown_adipose | 0.77528934 |
| 133 | MP0003172_abnormal_lysosome_physiology | 0.77152817 |
| 134 | MP0001529_abnormal_vocalization | 0.76367341 |
| 135 | MP0003879_abnormal_hair_cell | 0.76012322 |
| 136 | MP0002277_abnormal_respiratory_mucosa | 0.75692087 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74828837 |
| 138 | MP0003136_yellow_coat_color | 0.74765950 |
| 139 | MP0000049_abnormal_middle_ear | 0.74672964 |
| 140 | MP0002882_abnormal_neuron_morphology | 0.74333700 |
| 141 | MP0003566_abnormal_cell_adhesion | 0.73995077 |
| 142 | MP0003724_increased_susceptibility_to | 0.72946840 |
| 143 | MP0000477_abnormal_intestine_morphology | 0.72196830 |
| 144 | MP0001849_ear_inflammation | 0.71021980 |
| 145 | MP0003690_abnormal_glial_cell | 0.69312759 |
| 146 | MP0000604_amyloidosis | 0.68814862 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.67860694 |
| 148 | MP0005395_other_phenotype | 0.66145170 |
| 149 | MP0001765_abnormal_ion_homeostasis | 0.65673837 |
| 150 | MP0006054_spinal_hemorrhage | 0.65618365 |
| 151 | MP0003635_abnormal_synaptic_transmissio | 0.64877024 |
| 152 | MP0002970_abnormal_white_adipose | 0.64831221 |
| 153 | MP0005636_abnormal_mineral_homeostasis | 0.64138609 |
| 154 | MP0001958_emphysema | 0.63604071 |
| 155 | MP0005360_urolithiasis | 0.62140754 |
| 156 | MP0003828_pulmonary_edema | 0.61951622 |
| 157 | MP0002009_preneoplasia | 0.61539138 |
| 158 | MP0003453_abnormal_keratinocyte_physiol | 0.60560714 |
| 159 | MP0010678_abnormal_skin_adnexa | 0.59175099 |
| 160 | MP0000343_altered_response_to | 0.58238545 |
| 161 | MP0002078_abnormal_glucose_homeostasis | 0.58179827 |
| 162 | MP0003448_altered_tumor_morphology | 0.54700418 |
| 163 | MP0002148_abnormal_hypersensitivity_rea | 0.54414933 |
| 164 | MP0008873_increased_physiological_sensi | 0.53067379 |
| 165 | MP0001533_abnormal_skeleton_physiology | 0.52640667 |
| 166 | MP0004270_analgesia | 0.51676734 |
| 167 | MP0010386_abnormal_urinary_bladder | 0.50813838 |
| 168 | MP0003953_abnormal_hormone_level | 0.49631871 |
| 169 | MP0004782_abnormal_surfactant_physiolog | 0.49280127 |
| 170 | MP0001851_eye_inflammation | 0.49022462 |
| 171 | MP0001501_abnormal_sleep_pattern | 0.48793832 |
| 172 | MP0000465_gastrointestinal_hemorrhage | 0.47781190 |
| 173 | MP0002693_abnormal_pancreas_physiology | 0.47628704 |
| 174 | MP0005452_abnormal_adipose_tissue | 0.47166738 |
| 175 | MP0002063_abnormal_learning/memory/cond | 0.47031546 |
| 176 | MP0003436_decreased_susceptibility_to | 0.46345789 |
| 177 | MP0005319_abnormal_enzyme/_coenzyme | 0.46328032 |
| 178 | MP0005448_abnormal_energy_balance | 0.45336027 |
| 179 | MP0002452_abnormal_antigen_presenting | 0.44669546 |
| 180 | MP0005266_abnormal_metabolism | 0.44275126 |
| 181 | MP0000609_abnormal_liver_physiology | 0.43655568 |
| 182 | * MP0001845_abnormal_inflammatory_respons | 0.43592717 |
| 183 | MP0002896_abnormal_bone_mineralization | 0.42165395 |
| 184 | MP0008469_abnormal_protein_level | 0.41803774 |
| 185 | MP0009745_abnormal_behavioral_response | 0.40316151 |
| 186 | MP0002139_abnormal_hepatobiliary_system | 0.40186815 |
| 187 | MP0009780_abnormal_chondrocyte_physiolo | 0.40012087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 5.31305252 |
| 2 | Abnormality of purine metabolism (HP:0004352) | 5.08996266 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.84453418 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 4.78795859 |
| 5 | Pancreatic cysts (HP:0001737) | 4.51356733 |
| 6 | Axonal loss (HP:0003447) | 4.45856528 |
| 7 | Abnormality of midbrain morphology (HP:0002418) | 4.26479205 |
| 8 | Molar tooth sign on MRI (HP:0002419) | 4.26479205 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.15916646 |
| 10 | Pancreatic fibrosis (HP:0100732) | 4.14337860 |
| 11 | Arterial tortuosity (HP:0005116) | 4.10192400 |
| 12 | True hermaphroditism (HP:0010459) | 4.01822771 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.88919297 |
| 14 | Nephronophthisis (HP:0000090) | 3.75559175 |
| 15 | Tubulointerstitial fibrosis (HP:0005576) | 3.63498493 |
| 16 | Vascular tortuosity (HP:0004948) | 3.55122569 |
| 17 | Hyperventilation (HP:0002883) | 3.54452625 |
| 18 | Tubulointerstitial nephritis (HP:0001970) | 3.41184495 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 3.32595802 |
| 20 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.32595802 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.29077584 |
| 22 | Abnormality of the renal medulla (HP:0100957) | 3.23602485 |
| 23 | Stridor (HP:0010307) | 3.16170732 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 3.13919122 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 3.13850162 |
| 26 | Hyperuricemia (HP:0002149) | 3.11478383 |
| 27 | Increased purine levels (HP:0004368) | 3.11478383 |
| 28 | Amelogenesis imperfecta (HP:0000705) | 3.11014931 |
| 29 | Type II lissencephaly (HP:0007260) | 3.07996431 |
| 30 | Tubular atrophy (HP:0000092) | 3.04807772 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.97122183 |
| 32 | Cystic liver disease (HP:0006706) | 2.93910166 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.93582293 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.93521461 |
| 35 | Abolished electroretinogram (ERG) (HP:0000550) | 2.89055756 |
| 36 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.86918099 |
| 37 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.86918099 |
| 38 | Thin bony cortex (HP:0002753) | 2.84658977 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83430995 |
| 40 | Large for gestational age (HP:0001520) | 2.82945520 |
| 41 | Progressive cerebellar ataxia (HP:0002073) | 2.82745972 |
| 42 | Polydipsia (HP:0001959) | 2.79213743 |
| 43 | Abnormal drinking behavior (HP:0030082) | 2.79213743 |
| 44 | Genetic anticipation (HP:0003743) | 2.79014299 |
| 45 | Congenital, generalized hypertrichosis (HP:0004540) | 2.78077348 |
| 46 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.74867899 |
| 47 | Inability to walk (HP:0002540) | 2.74383861 |
| 48 | Aortic aneurysm (HP:0004942) | 2.71976627 |
| 49 | Increased corneal curvature (HP:0100692) | 2.71917028 |
| 50 | Keratoconus (HP:0000563) | 2.71917028 |
| 51 | Syncope (HP:0001279) | 2.68400764 |
| 52 | Protruding tongue (HP:0010808) | 2.67929079 |
| 53 | Chronic hepatic failure (HP:0100626) | 2.63606117 |
| 54 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.60904235 |
| 55 | Cortical dysplasia (HP:0002539) | 2.60239860 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.60135468 |
| 57 | Neurodegeneration (HP:0002180) | 2.59740071 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.59415836 |
| 59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59373063 |
| 60 | Abnormality of alanine metabolism (HP:0010916) | 2.59373063 |
| 61 | Hyperalaninemia (HP:0003348) | 2.59373063 |
| 62 | Visual hallucinations (HP:0002367) | 2.58332592 |
| 63 | Abnormality of renal excretion (HP:0011036) | 2.57636209 |
| 64 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.57517796 |
| 65 | Aortic dissection (HP:0002647) | 2.57481799 |
| 66 | Abnormality of vitamin B metabolism (HP:0004340) | 2.55609117 |
| 67 | Sclerocornea (HP:0000647) | 2.55106342 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.54168474 |
| 69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.54168474 |
| 70 | Eczematoid dermatitis (HP:0000976) | 2.50458306 |
| 71 | Megaloblastic anemia (HP:0001889) | 2.50457092 |
| 72 | Glomerulosclerosis (HP:0000096) | 2.50023374 |
| 73 | Decreased central vision (HP:0007663) | 2.49499898 |
| 74 | Renal salt wasting (HP:0000127) | 2.47822440 |
| 75 | Gait imbalance (HP:0002141) | 2.47195158 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.46720012 |
| 77 | Progressive inability to walk (HP:0002505) | 2.43935712 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.43921857 |
| 79 | Furrowed tongue (HP:0000221) | 2.43435120 |
| 80 | Subcapsular cataract (HP:0000523) | 2.43383094 |
| 81 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.40801331 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.39587210 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34738047 |
| 84 | Concave nail (HP:0001598) | 2.33902585 |
| 85 | Lissencephaly (HP:0001339) | 2.33866476 |
| 86 | Curly hair (HP:0002212) | 2.33205190 |
| 87 | Goiter (HP:0000853) | 2.32838513 |
| 88 | Clumsiness (HP:0002312) | 2.31806121 |
| 89 | Congenital primary aphakia (HP:0007707) | 2.31680899 |
| 90 | Abnormal ciliary motility (HP:0012262) | 2.30942358 |
| 91 | Ketoacidosis (HP:0001993) | 2.29683513 |
| 92 | Frequent falls (HP:0002359) | 2.29436141 |
| 93 | Pendular nystagmus (HP:0012043) | 2.28820902 |
| 94 | Supranuclear gaze palsy (HP:0000605) | 2.26499100 |
| 95 | Nephrogenic diabetes insipidus (HP:0009806) | 2.26438796 |
| 96 | Ventricular fibrillation (HP:0001663) | 2.26263757 |
| 97 | Pili torti (HP:0003777) | 2.25825085 |
| 98 | Patellar aplasia (HP:0006443) | 2.24314921 |
| 99 | Broad-based gait (HP:0002136) | 2.24139923 |
| 100 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.22453255 |
| 101 | Hypoplasia of the fovea (HP:0007750) | 2.22331952 |
| 102 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.22331952 |
| 103 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22054985 |
| 104 | Pustule (HP:0200039) | 2.22004808 |
| 105 | Metaphyseal dysplasia (HP:0100255) | 2.21247762 |
| 106 | Polyuria (HP:0000103) | 2.21141467 |
| 107 | Bilateral microphthalmos (HP:0007633) | 2.21044014 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 2.20158494 |
| 109 | Protuberant abdomen (HP:0001538) | 2.20016226 |
| 110 | Febrile seizures (HP:0002373) | 2.19671719 |
| 111 | Congenital hepatic fibrosis (HP:0002612) | 2.19547665 |
| 112 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.17506771 |
| 113 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.16949223 |
| 114 | Nephritis (HP:0000123) | 2.16803206 |
| 115 | Neurofibrillary tangles (HP:0002185) | 2.16539100 |
| 116 | Male pseudohermaphroditism (HP:0000037) | 2.13810320 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 2.11658419 |
| 118 | Spastic tetraparesis (HP:0001285) | 2.11584285 |
| 119 | Hematochezia (HP:0002573) | 2.11130617 |
| 120 | Poor eye contact (HP:0000817) | 2.11099785 |
| 121 | Fatigue (HP:0012378) | 2.11091065 |
| 122 | Anencephaly (HP:0002323) | 2.10745060 |
| 123 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.10098284 |
| 124 | Abnormal social behavior (HP:0012433) | 2.09272701 |
| 125 | Impaired social interactions (HP:0000735) | 2.09272701 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 2.09017525 |
| 127 | Cerebellar dysplasia (HP:0007033) | 2.07483932 |
| 128 | Recurrent bacterial skin infections (HP:0005406) | 2.04359478 |
| 129 | Focal motor seizures (HP:0011153) | 2.03005154 |
| 130 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.02713980 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02147049 |
| 132 | Mucopolysacchariduria (HP:0008155) | 2.02147049 |
| 133 | Renal cortical cysts (HP:0000803) | 1.98890203 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98825607 |
| 135 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98825607 |
| 136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98825607 |
| 137 | Apathy (HP:0000741) | 1.97254606 |
| 138 | Hemiparesis (HP:0001269) | 1.96969354 |
| 139 | Focal seizures (HP:0007359) | 1.95946550 |
| 140 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95798654 |
| 141 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95798654 |
| 142 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95798654 |
| 143 | Genital tract atresia (HP:0001827) | 1.95337198 |
| 144 | Abnormality of macrophages (HP:0004311) | 1.94654175 |
| 145 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.94398659 |
| 146 | Vaginal atresia (HP:0000148) | 1.93351729 |
| 147 | Abnormality of the pons (HP:0007361) | 1.93066108 |
| 148 | Hypoplasia of the pons (HP:0012110) | 1.92017675 |
| 149 | Hyperglycinuria (HP:0003108) | 1.91276373 |
| 150 | Vascular calcification (HP:0004934) | 1.91224800 |
| 151 | Bile duct proliferation (HP:0001408) | 1.91114209 |
| 152 | Abnormal biliary tract physiology (HP:0012439) | 1.91114209 |
| 153 | Agitation (HP:0000713) | 1.89202933 |
| 154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88489523 |
| 155 | Rapidly progressive (HP:0003678) | 1.85981008 |
| 156 | Recurrent abscess formation (HP:0002722) | 1.85525867 |
| 157 | Aneurysm (HP:0002617) | 1.85346165 |
| 158 | Hyperkalemia (HP:0002153) | 1.84237981 |
| 159 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.84160464 |
| 160 | Fair hair (HP:0002286) | 1.84089114 |
| 161 | Dialeptic seizures (HP:0011146) | 1.83411339 |
| 162 | Severe muscular hypotonia (HP:0006829) | 1.82586129 |
| 163 | Diminished motivation (HP:0000745) | 1.82180058 |
| 164 | Achilles tendon contracture (HP:0001771) | 1.80439563 |
| 165 | Hypoplasia of dental enamel (HP:0006297) | 1.80121058 |
| 166 | Bone cyst (HP:0012062) | 1.78737907 |
| 167 | Striae distensae (HP:0001065) | 1.78721673 |
| 168 | Constricted visual fields (HP:0001133) | 1.78545309 |
| 169 | Hypothermia (HP:0002045) | 1.78300001 |
| 170 | Postaxial foot polydactyly (HP:0001830) | 1.78229336 |
| 171 | Periodontitis (HP:0000704) | 1.77227992 |
| 172 | Abdominal distention (HP:0003270) | 1.76698946 |
| 173 | Optic nerve hypoplasia (HP:0000609) | 1.76399178 |
| 174 | Abnormality of the fovea (HP:0000493) | 1.76051821 |
| 175 | Paresthesia (HP:0003401) | 1.75651406 |
| 176 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.75367381 |
| 177 | Tubulointerstitial abnormality (HP:0001969) | 1.74931988 |
| 178 | Epiphyseal dysplasia (HP:0002656) | 1.74491320 |
| 179 | Chorioretinal atrophy (HP:0000533) | 1.73947152 |
| 180 | Abnormal urine output (HP:0012590) | 1.73333766 |
| 181 | Tachypnea (HP:0002789) | 1.73324343 |
| 182 | Ventricular arrhythmia (HP:0004308) | 1.72057889 |
| 183 | Chronic sinusitis (HP:0011109) | 1.72031579 |
| 184 | Birth length less than 3rd percentile (HP:0003561) | 1.71751284 |
| 185 | Deep venous thrombosis (HP:0002625) | 1.71604505 |
| 186 | Hyperactive renin-angiotensin system (HP:0000841) | 1.71314838 |
| 187 | Absent speech (HP:0001344) | 1.71191196 |
| 188 | Hypoplastic ischia (HP:0003175) | 1.70832911 |
| 189 | Long toe (HP:0010511) | 1.70401495 |
| 190 | Woolly hair (HP:0002224) | 1.70103579 |
| 191 | Abnormality of vision evoked potentials (HP:0000649) | 1.69751746 |
| 192 | Poor coordination (HP:0002370) | 1.69509551 |
| 193 | Premature loss of primary teeth (HP:0006323) | 1.69217942 |
| 194 | Cardiovascular calcification (HP:0011915) | 1.69123145 |
| 195 | Enlarged penis (HP:0000040) | 1.68769129 |
| 196 | Retinitis pigmentosa (HP:0000510) | 1.67323123 |
| 197 | Global brain atrophy (HP:0002283) | 1.64842373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB4 | 4.89700890 |
| 2 | PKN2 | 3.86820272 |
| 3 | TRIB3 | 3.53599822 |
| 4 | ADRBK2 | 3.48094309 |
| 5 | CAMK1D | 3.37627790 |
| 6 | BMPR1B | 2.86384801 |
| 7 | CAMK1G | 2.80144870 |
| 8 | KSR2 | 2.77278540 |
| 9 | CASK | 2.71063453 |
| 10 | GRK1 | 2.67386656 |
| 11 | INSRR | 2.66096842 |
| 12 | PINK1 | 2.51546314 |
| 13 | ZAK | 2.47947336 |
| 14 | MST4 | 2.44946629 |
| 15 | WNK3 | 2.43277306 |
| 16 | MAP3K9 | 2.40644629 |
| 17 | ACVR1B | 2.38008021 |
| 18 | SIK1 | 2.26669062 |
| 19 | TLK1 | 2.15464424 |
| 20 | MST1R | 2.10546617 |
| 21 | EEF2K | 2.08533642 |
| 22 | PDK2 | 2.06527587 |
| 23 | FGR | 2.00297009 |
| 24 | MAP4K2 | 1.94810459 |
| 25 | RIPK4 | 1.94370495 |
| 26 | MAPK13 | 1.89422744 |
| 27 | ERN1 | 1.86561642 |
| 28 | PDK4 | 1.80382025 |
| 29 | PDK3 | 1.80382025 |
| 30 | MAP3K13 | 1.79832644 |
| 31 | TXK | 1.73736999 |
| 32 | OXSR1 | 1.72141130 |
| 33 | TGFBR2 | 1.53282771 |
| 34 | PNCK | 1.47248029 |
| 35 | MAP3K4 | 1.46631758 |
| 36 | LRRK2 | 1.44299094 |
| 37 | MARK1 | 1.43918413 |
| 38 | PDGFRB | 1.43906552 |
| 39 | STK10 | 1.42959520 |
| 40 | ZAP70 | 1.42829646 |
| 41 | PTK6 | 1.41371487 |
| 42 | RIPK1 | 1.39216563 |
| 43 | DAPK2 | 1.38494771 |
| 44 | MAP3K2 | 1.34466575 |
| 45 | CAMKK2 | 1.33602019 |
| 46 | FER | 1.31166966 |
| 47 | ADRBK1 | 1.28578326 |
| 48 | MAP4K1 | 1.27685983 |
| 49 | MOS | 1.27565197 |
| 50 | SIK2 | 1.20438490 |
| 51 | MAP3K7 | 1.18804530 |
| 52 | FES | 1.18291867 |
| 53 | TNIK | 1.17251057 |
| 54 | PTK2B | 1.16299431 |
| 55 | PRKCG | 1.14226214 |
| 56 | BCKDK | 1.11782447 |
| 57 | CAMKK1 | 1.10772968 |
| 58 | ARAF | 1.10645095 |
| 59 | DYRK2 | 1.10277817 |
| 60 | PRKAA2 | 1.07211930 |
| 61 | DMPK | 1.05217675 |
| 62 | RET | 1.04918105 |
| 63 | NTRK3 | 1.02726030 |
| 64 | MAPK15 | 1.02140525 |
| 65 | MAP2K7 | 1.02080440 |
| 66 | PAK3 | 0.97506538 |
| 67 | LMTK2 | 0.97429258 |
| 68 | MKNK2 | 0.96565720 |
| 69 | MYLK | 0.95220798 |
| 70 | TTN | 0.94479622 |
| 71 | CDK19 | 0.94351142 |
| 72 | TGFBR1 | 0.94178441 |
| 73 | TIE1 | 0.93873565 |
| 74 | GRK6 | 0.92787003 |
| 75 | MAP2K1 | 0.90502905 |
| 76 | NME1 | 0.90180851 |
| 77 | FRK | 0.89701745 |
| 78 | NTRK2 | 0.89311686 |
| 79 | PRKCE | 0.88933455 |
| 80 | PAK6 | 0.87999861 |
| 81 | STK38 | 0.87289867 |
| 82 | PDPK1 | 0.85190207 |
| 83 | MAPKAPK3 | 0.84989516 |
| 84 | PDK1 | 0.82973808 |
| 85 | BMX | 0.82248367 |
| 86 | EPHA4 | 0.81668702 |
| 87 | KSR1 | 0.80929598 |
| 88 | TYRO3 | 0.80309152 |
| 89 | RAF1 | 0.78683117 |
| 90 | MET | 0.75974424 |
| 91 | STK11 | 0.75133365 |
| 92 | PHKG1 | 0.74548594 |
| 93 | PHKG2 | 0.74548594 |
| 94 | GRK5 | 0.74161214 |
| 95 | PIK3CG | 0.73329550 |
| 96 | RPS6KA2 | 0.71378553 |
| 97 | CSNK1G2 | 0.70958491 |
| 98 | NEK2 | 0.67822338 |
| 99 | PRKD3 | 0.66913837 |
| 100 | TAOK1 | 0.65983808 |
| 101 | MUSK | 0.65607437 |
| 102 | TEC | 0.64857490 |
| 103 | NTRK1 | 0.64574839 |
| 104 | DDR2 | 0.64316733 |
| 105 | PKN1 | 0.64162224 |
| 106 | EPHB1 | 0.63819069 |
| 107 | MAP3K12 | 0.62403321 |
| 108 | IRAK1 | 0.62326778 |
| 109 | PLK2 | 0.60762092 |
| 110 | MATK | 0.60055029 |
| 111 | PTK2 | 0.58922797 |
| 112 | TRPM7 | 0.58690935 |
| 113 | GRK7 | 0.58334681 |
| 114 | CDK9 | 0.57311611 |
| 115 | MAP3K1 | 0.57023551 |
| 116 | MAPKAPK5 | 0.56465448 |
| 117 | JAK2 | 0.56021940 |
| 118 | CSK | 0.55922029 |
| 119 | STK38L | 0.55496635 |
| 120 | PRKACA | 0.54593962 |
| 121 | FGFR2 | 0.54415602 |
| 122 | DAPK1 | 0.54140878 |
| 123 | ITK | 0.52937026 |
| 124 | OBSCN | 0.51870894 |
| 125 | CSNK1G1 | 0.51614548 |
| 126 | MAP2K6 | 0.51401353 |
| 127 | WNK4 | 0.50731723 |
| 128 | RPS6KA5 | 0.50021108 |
| 129 | TAOK3 | 0.49278027 |
| 130 | CSNK1G3 | 0.49214173 |
| 131 | KIT | 0.49196787 |
| 132 | MAP2K4 | 0.48784277 |
| 133 | TBK1 | 0.48654434 |
| 134 | VRK1 | 0.48309472 |
| 135 | MINK1 | 0.48207511 |
| 136 | PRKCZ | 0.47917482 |
| 137 | IKBKB | 0.47284654 |
| 138 | FYN | 0.46717616 |
| 139 | BCR | 0.44375894 |
| 140 | PRKCH | 0.44136455 |
| 141 | EPHA3 | 0.44104456 |
| 142 | RPS6KA6 | 0.43983288 |
| 143 | PRKCA | 0.43279658 |
| 144 | MAP2K2 | 0.42557037 |
| 145 | ERBB2 | 0.42334193 |
| 146 | PLK4 | 0.41940500 |
| 147 | MAPK12 | 0.41589271 |
| 148 | LIMK1 | 0.41472853 |
| 149 | ABL2 | 0.40779162 |
| 150 | TAF1 | 0.40747262 |
| 151 | STK3 | 0.40674304 |
| 152 | CAMK2A | 0.40321442 |
| 153 | CSNK1A1 | 0.40242257 |
| 154 | PRKCQ | 0.39610284 |
| 155 | PIK3CA | 0.39152514 |
| 156 | STK39 | 0.39068640 |
| 157 | JAK1 | 0.38637311 |
| 158 | CSNK1A1L | 0.38504287 |
| 159 | PRKAA1 | 0.38123776 |
| 160 | LATS1 | 0.37350795 |
| 161 | CDK5 | 0.37083118 |
| 162 | SYK | 0.36954058 |
| 163 | MAP3K6 | 0.36745707 |
| 164 | EGFR | 0.35969979 |
| 165 | CAMK1 | 0.35828350 |
| 166 | DYRK1A | 0.35784549 |
| 167 | TRIM28 | 0.35511818 |
| 168 | BMPR2 | 0.35230778 |
| 169 | PRKG1 | 0.34860159 |
| 170 | PRKCI | 0.34686773 |
| 171 | CHUK | 0.34566280 |
| 172 | MAP3K8 | 0.34365087 |
| 173 | CSNK1D | 0.34113717 |
| 174 | SRC | 0.33451728 |
| 175 | MAP3K11 | 0.31850959 |
| 176 | WEE1 | 0.31384087 |
| 177 | SGK2 | 0.31137739 |
| 178 | NUAK1 | 0.30157033 |
| 179 | CAMK4 | 0.30118200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.99993058 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.93555218 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.32657919 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.93181457 |
| 5 | * Gastric acid secretion_Homo sapiens_hsa04971 | 2.80763397 |
| 6 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.77977969 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38705855 |
| 8 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.20018996 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16222912 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.14903480 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.14470840 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99777739 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 1.91167446 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.90523687 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85673462 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.73207139 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72737227 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.70067217 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.69005187 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.66373223 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.62765879 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59080081 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.57407839 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52386495 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48722094 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48507910 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.46303761 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.45635053 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44398140 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42354015 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36856375 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36280160 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30607673 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29082949 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25141068 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24223715 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.18928951 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.15080577 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.14367202 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.10841900 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10634601 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10406804 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.10114662 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09721369 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 1.08853582 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08756083 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06899628 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.05565020 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.04598581 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03249721 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01969966 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00296053 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97962591 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97830639 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 0.96632966 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.95918146 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94126022 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.93344902 |
| 59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93225824 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92806130 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92593973 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.92147039 |
| 63 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.90639305 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89391421 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88722150 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.88076920 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86845686 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83348562 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80656620 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79034092 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78614380 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75944367 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75885690 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73044827 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72830780 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70224942 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69734533 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69696774 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69231002 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68536877 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67541391 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66952245 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65960138 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65104840 |
| 85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65102720 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64661749 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.64402691 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64257642 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63526121 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63162283 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62990895 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62531473 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61549296 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61260767 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.60007736 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59624910 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59216832 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59182767 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58858936 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.58652813 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.58041134 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57414449 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.57135663 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56989016 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56114586 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56086482 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55534083 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55367853 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52935607 |
| 110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52836238 |
| 111 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52232692 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51169370 |
| 113 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.51019376 |
| 114 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50942206 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.49462168 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48341115 |
| 117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47526829 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47336772 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46864452 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46719444 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46395264 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46225738 |
| 123 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46080654 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.46032162 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45428262 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44865904 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44838978 |
| 128 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44527307 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.41751436 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41748924 |
| 131 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41211690 |
| 132 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40381646 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.39889875 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39243280 |
| 135 | Long-term depression_Homo sapiens_hsa04730 | 0.38864765 |
| 136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38711511 |
| 137 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38020705 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37505441 |
| 139 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36767946 |
| 140 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36596961 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36452705 |
| 142 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35616823 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35545714 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.35107181 |
| 145 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35033831 |
| 146 | Tight junction_Homo sapiens_hsa04530 | 0.34730383 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33938158 |
| 148 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33920473 |
| 149 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33672614 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33638400 |
| 151 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33353522 |
| 152 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33269813 |
| 153 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33213320 |
| 154 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32863863 |
| 155 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31712835 |

